ACADIA Pharmaceuticals Inc (ACAD)
16.60
-0.13
(-0.78%)
USD |
NASDAQ |
Apr 24, 16:00
16.60
0.00 (0.00%)
After-Hours: 17:21
ACADIA Pharmaceuticals Cash from Investing (Quarterly): -0.347M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.347M |
| September 30, 2023 | 34.11M |
| June 30, 2023 | -194.28M |
| March 31, 2023 | 192.52M |
| December 31, 2022 | -17.75M |
| September 30, 2022 | 15.44M |
| June 30, 2022 | -55.80M |
| March 31, 2022 | 131.34M |
| December 31, 2021 | 71.55M |
| September 30, 2021 | -156.32M |
| June 30, 2021 | -17.21M |
| March 31, 2021 | 30.88M |
| December 31, 2020 | -116.96M |
| September 30, 2020 | 152.99M |
| June 30, 2020 | 126.86M |
| March 31, 2020 | 29.61M |
| December 31, 2019 | -209.14M |
| September 30, 2019 | 9.923M |
| June 30, 2019 | 10.63M |
| March 31, 2019 | 22.76M |
| December 31, 2018 | -188.95M |
| September 30, 2018 | 31.78M |
| June 30, 2018 | -3.942M |
| March 31, 2018 | 89.62M |
| December 31, 2017 | -18.09M |
| Date | Value |
|---|---|
| September 30, 2017 | 19.33M |
| June 30, 2017 | 38.30M |
| March 31, 2017 | 52.94M |
| December 31, 2016 | 69.14M |
| September 30, 2016 | -154.91M |
| June 30, 2016 | -7.46M |
| March 31, 2016 | -168.70M |
| December 31, 2015 | 56.72M |
| September 30, 2015 | 8.308M |
| June 30, 2015 | 44.06M |
| March 31, 2015 | 38.47M |
| December 31, 2014 | 40.48M |
| September 30, 2014 | 38.87M |
| June 30, 2014 | -67.51M |
| March 31, 2014 | -99.11M |
| December 31, 2013 | 9.541M |
| September 30, 2013 | -3.943M |
| June 30, 2013 | -98.62M |
| March 31, 2013 | -33.09M |
| December 31, 2012 | -35.05M |
| September 30, 2012 | -2.744M |
| June 30, 2012 | 8.393M |
| March 31, 2012 | 3.877M |
| December 31, 2011 | 3.815M |
| September 30, 2011 | 4.478M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-209.14M
Minimum
Dec 2019
192.52M
Maximum
Mar 2023
2.003M
Average
10.63M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -0.431M |
| Amylyx Pharmaceuticals Inc | 20.92M |
| Regulus Therapeutics Inc | 4.932M |
| Minerva Neurosciences Inc | 0.00 |
| Viking Therapeutics Inc | 35.73M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 85.39M |
| Cash from Financing (Quarterly) | 5.434M |
| Free Cash Flow | -23.35M |
| Free Cash Flow Per Share (Quarterly) | 0.5181 |
| Free Cash Flow to Equity (Quarterly) | 85.39M |
| Free Cash Flow to Firm (Quarterly) | 85.39M |
| Free Cash Flow Yield | -0.86% |